Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Nov;31(11):1657–1661. doi: 10.1128/aac.31.11.1657

Effects of beta-lactam antibiotics on proliferating eucaryotic cells.

K A Neftel 1, U Hübscher 1
PMCID: PMC175015  PMID: 3324959

Full text

PDF
1659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banck G., Forsgren A. Antibiotics and suppression of lymphocyte function in vitro. Antimicrob Agents Chemother. 1979 Nov;16(5):554–560. doi: 10.1128/aac.16.5.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown K. N., Percival A. Penetration of antimicrobials into tissue culture cells and leucocytes. Scand J Infect Dis Suppl. 1978;(14):251–260. [PubMed] [Google Scholar]
  3. Chaperon E. A., Sanders W. E., Jr Suppression of lymphocyte responses by cephalosporins. Infect Immun. 1978 Feb;19(2):378–384. doi: 10.1128/iai.19.2.378-384.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cottagnoud P., Neftel K. A. Beta-lactams act on DNA synthesis in K-562 cells. Cell Biol Toxicol. 1986 Dec;2(4):523–529. doi: 10.1007/BF00117854. [DOI] [PubMed] [Google Scholar]
  5. Daschner F. D. Antibiotics and host defence with special reference to phagocytosis by human polymorphonuclear leukocytes. J Antimicrob Chemother. 1985 Aug;16(2):135–141. doi: 10.1093/jac/16.2.135. [DOI] [PubMed] [Google Scholar]
  6. Doherty J. B., Ashe B. M., Argenbright L. W., Barker P. L., Bonney R. J., Chandler G. O., Dahlgren M. E., Dorn C. P., Jr, Finke P. E., Firestone R. A. Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase. Nature. 1986 Jul 10;322(6075):192–194. doi: 10.1038/322192a0. [DOI] [PubMed] [Google Scholar]
  7. EAGLE H. The binding of penicillin in relation to its cytotoxic action. III. The binding of penicillin by mammalian cells in tissue culture (HeLa and L strains). J Exp Med. 1954 Jul 1;100(1):117–124. doi: 10.1084/jem.100.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eltahawy A. T. The penetration of mammalian cells by antibiotics. J Antimicrob Chemother. 1983 Apr;11(4):293–298. doi: 10.1093/jac/11.4.293. [DOI] [PubMed] [Google Scholar]
  9. Erffmeyer J. E. Adverse reactions to penicillin. Part II. Ann Allergy. 1981 Oct;47(4):294–300. [PubMed] [Google Scholar]
  10. Floersheim G. L. Antidotes to experimental -amanitin poisoning. Nat New Biol. 1972 Mar 29;236(65):115–117. doi: 10.1038/newbio236115a0. [DOI] [PubMed] [Google Scholar]
  11. Floersheim G. L., Eberhard M., Tschumi P., Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978 Nov;46(2):455–462. doi: 10.1016/0041-008x(78)90091-1. [DOI] [PubMed] [Google Scholar]
  12. Forsgren A., Bellahsène A. Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scand J Infect Dis Suppl. 1985;44:16–23. [PubMed] [Google Scholar]
  13. Goetz I. E., Moklebust R., Warren C. J. Effects of some antibiotics on the growth of human diploid skin fibroblasts in cell culture. In Vitro. 1979 Feb;15(2):114–119. doi: 10.1007/BF02618107. [DOI] [PubMed] [Google Scholar]
  14. Hand W. L., Boozer R. M., King-Thompson N. L. Antibiotic uptake by alveolar macrophages of smokers. Antimicrob Agents Chemother. 1985 Jan;27(1):42–45. doi: 10.1128/aac.27.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hauser W. E., Jr, Remington J. S. Effect of antibiotics on the immune response. Am J Med. 1982 May;72(5):711–716. doi: 10.1016/0002-9343(82)90534-4. [DOI] [PubMed] [Google Scholar]
  16. Huegin A. W., Cerny A., Zinkernagel R. M., Neftel K. A. Suppressive effects of B-lactam-antibiotics on in vitro generation of cytotoxic T-cells. Int J Immunopharmacol. 1986;8(7):723–729. doi: 10.1016/0192-0561(86)90008-1. [DOI] [PubMed] [Google Scholar]
  17. Hübscher U., Huynh U. D., Hässig M., Neftel K. A. Effects of beta-lactams on DNA replication. Cell Biol Toxicol. 1986 Dec;2(4):541–548. doi: 10.1007/BF00117856. [DOI] [PubMed] [Google Scholar]
  18. Jacobs R. F., Wilson C. B., Laxton J. G., Haas J. E., Smith A. L. Cellular uptake and intracellular activity of antibiotics against Haemophilus influenzae type b. J Infect Dis. 1982 Feb;145(2):152–159. doi: 10.1093/infdis/145.2.152. [DOI] [PubMed] [Google Scholar]
  19. Kornguth M. L., Kunin C. M. Uptake of antibiotics by human erythrocytes. J Infect Dis. 1976 Feb;133(2):175–184. doi: 10.1093/infdis/133.2.175. [DOI] [PubMed] [Google Scholar]
  20. Lange A., Assmann G. Penetration von Penicillin G und Ampicillin in Mäusefibroblasten (Earle's strain L). Auswirkungen von Temperatur und Serumgehalt des Nährmediums. Z Med Mikrobiol Immunol. 1966;153(1):60–67. [PubMed] [Google Scholar]
  21. Larson S. E., DaMert G. J., Collins-Lech C., Sohnle P. G. Direct stimulation of lymphokine production by cephalothin. J Infect Dis. 1980 Aug;142(2):265–272. doi: 10.1093/infdis/142.2.265. [DOI] [PubMed] [Google Scholar]
  22. Manzella J. P., Clark J. K. Effects of moxalactam and cefuroxime on mitogen-stimulated human mononuclear leukocytes. Antimicrob Agents Chemother. 1983 Mar;23(3):360–363. doi: 10.1128/aac.23.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Marie J. P., Thevenin D., Zittoun R. Inhibition de la granulopoiése in vitro par les bêta-lactamines Comparaison entre pipéracilline, mezlocilline, ceftriaxone et ceftazidime. Presse Med. 1986 Dec 20;15(46):2358–2361. [PubMed] [Google Scholar]
  24. Maruyama T., Uchida K., Hara H. Suppressive effect of antibiotics on colony formation from human megakaryocyte progenitors (CFU-M) and granulocyte-macrophage progenitors (CFU-GM). Jpn J Pharmacol. 1987 Apr;43(4):423–428. doi: 10.1254/jjp.43.423. [DOI] [PubMed] [Google Scholar]
  25. Milatovic D. Antibiotics and phagocytosis. Eur J Clin Microbiol. 1983 Oct;2(5):414–425. doi: 10.1007/BF02013898. [DOI] [PubMed] [Google Scholar]
  26. Neftel K. A., Hauser S. P., Müller M. R. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis. 1985 Jul;152(1):90–98. doi: 10.1093/infdis/152.1.90. [DOI] [PubMed] [Google Scholar]
  27. Neftel K. A., Müller M. R., Widmer U., Hügin A. W. Beta-lactam antibiotics inhibit human in vitro granulopoiesis and proliferation of some other cell types. Cell Biol Toxicol. 1986 Dec;2(4):513–521. doi: 10.1007/BF00117853. [DOI] [PubMed] [Google Scholar]
  28. Neftel K. A., Müller M. R., Wälti M., Erni J., Gugler M., Arrenbrecht S. Penicillin-G degradation products inhibit in vitro granulopoiesis. Br J Haematol. 1983 Jun;54(2):255–260. doi: 10.1111/j.1365-2141.1983.tb02093.x. [DOI] [PubMed] [Google Scholar]
  29. Neftel K. A., Wälti M., Schulthess H. K., Gubler J. Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro. Klin Wochenschr. 1984 Jan 2;62(1):25–29. doi: 10.1007/BF01725189. [DOI] [PubMed] [Google Scholar]
  30. Nozaki Y., Katayama N., Ono H., Tsubotani S., Harada S., Okazaki H., Nakao Y. Binding of a non-beta-lactam antibiotic to penicillin-binding proteins. Nature. 1987 Jan 8;325(7000):179–180. doi: 10.1038/325179a0. [DOI] [PubMed] [Google Scholar]
  31. Oleske J. M. Effects of antimicrobials on host defence mechanism. J Antimicrob Chemother. 1984 May;13(5):413–415. doi: 10.1093/jac/13.5.413. [DOI] [PubMed] [Google Scholar]
  32. Onorato I. M., Axelrod J. L. Hepatitis from intravenous high-dose oxacillin therapy: findings in an adult inpatient population. Ann Intern Med. 1978 Oct;89(4):497–500. doi: 10.7326/0003-4819-89-4-497. [DOI] [PubMed] [Google Scholar]
  33. Peterson P. K. How antibiotics augment host defenses. Eur J Clin Microbiol. 1982 Dec;1(6):335–337. doi: 10.1007/BF02019930. [DOI] [PubMed] [Google Scholar]
  34. Prokesch R. C., Hand W. L. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982 Mar;21(3):373–380. doi: 10.1128/aac.21.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Renard C., Vanderhaeghe H. J., Claes P. J., Zenebergh A., Tulkens P. M. Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother. 1987 Mar;31(3):410–416. doi: 10.1128/aac.31.3.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Roszkowski W., Ko H. L., Roszkowski K., Jeljaszewicz J., Pulverer G. Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin. Med Microbiol Immunol. 1985;173(5):279–289. doi: 10.1007/BF02124944. [DOI] [PubMed] [Google Scholar]
  37. Sanders W. E., Jr, Johnson J. E., 3rd, Taggart J. G. Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses. N Engl J Med. 1974 Feb 21;290(8):424–429. doi: 10.1056/NEJM197402212900803. [DOI] [PubMed] [Google Scholar]
  38. Sanjad S. A., Haddad G. G., Nassar V. H. Nephropathy, an underestimated complication of methicillin therapy. J Pediatr. 1974 Jun;84(6):873–877. doi: 10.1016/s0022-3476(74)80771-7. [DOI] [PubMed] [Google Scholar]
  39. Schwarze P. E., Seglen P. O. Effects of antibiotics on protein synthesis and degradation in primary cultures of rat hepatocytes. In Vitro. 1981 Jan;17(1):71–76. doi: 10.1007/BF02618033. [DOI] [PubMed] [Google Scholar]
  40. Tamai I., Terasaki T., Tsuji A. Evidence for the existence of a common transport system of beta-lactam antibiotics in isolated rat hepatocytes. J Antibiot (Tokyo) 1985 Dec;38(12):1774–1780. doi: 10.7164/antibiotics.38.1774. [DOI] [PubMed] [Google Scholar]
  41. Vonen B., Mørland J. Penicillin toxicity in isolated rat hepatocytes revealed by decreased incorporation of valine into proteins. Acta Pharmacol Toxicol (Copenh) 1982 Aug;51(2):81–86. doi: 10.1111/j.1600-0773.1982.tb00995.x. [DOI] [PubMed] [Google Scholar]
  42. Weston B. J., Spackman V. M., Dewdney J. M. Effect of beta-lactam antibiotics on a human myeloid cell line: investigation of potential in vivo correlates in the mouse. Cell Biol Toxicol. 1986 Dec;2(4):549–557. doi: 10.1007/BF00117857. [DOI] [PubMed] [Google Scholar]
  43. Winston D. J., Barnes R. C., Ho W. G., Young L. S., Champlin R. E., Gale R. P. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am J Med. 1984 Sep;77(3):442–450. doi: 10.1016/0002-9343(84)90100-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES